Shimada Itsuro, Maeno Kyoichi, Kondoh Yutaka, Kaku Hidetaka, Sugasawa Keizo, Kimura Yasuharu, Hatanaka Ken-ichi, Naitou Yuki, Wanibuchi Fumikazu, Sakamoto Shuichi, Tsukamoto Shin-ichi
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.
Bioorg Med Chem. 2008 Mar 15;16(6):3309-20. doi: 10.1016/j.bmc.2007.12.009. Epub 2007 Dec 8.
To identify potent and selective 5-HT(2C) receptor agonists, a series of novel benzazepine derivatives were synthesized, and their structure-activity relationships examined. The compounds were evaluated for their 5-HT(2C), 5-HT(2A), and 5-HT(2B) receptor binding affinity and intrinsic activity for the 5-HT(2C) and 5-HT(2A) receptors. Among these compounds, 6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine (6) was effective in a rat penile erection model when administered po, which is a symptom of the serotonin syndrome reflecting 5-HT(2C) receptor activation. Moreover, compound 6 was characterized as a partial agonist of 5-HT(2A) receptors; therefore, it had little effect on the cardiovascular system.
为了鉴定强效且选择性的5-羟色胺(5-HT)2C受体激动剂,合成了一系列新型苯并氮杂卓衍生物,并研究了它们的构效关系。评估了这些化合物对5-HT2C、5-HT2A和5-HT2B受体的结合亲和力以及对5-HT2C和5-HT2A受体的内在活性。在这些化合物中,6,7-二氯-2,3,4,5-四氢-1H-3-苯并氮杂卓(6)经口服给药时在大鼠阴茎勃起模型中有效,这是反映5-HT2C受体激活的血清素综合征的一种症状。此外,化合物6被表征为5-HT2A受体的部分激动剂;因此,它对心血管系统几乎没有影响。